Spectro-Holographic Instrument for Dynamic Sensing of Cancer Progression

Information

  • Research Project
  • 10236304
  • ApplicationId
    10236304
  • Core Project Number
    R01CA228029
  • Full Project Number
    5R01CA228029-04
  • Serial Number
    228029
  • FOA Number
    PA-16-160
  • Sub Project Id
  • Project Start Date
    9/1/2018 - 6 years ago
  • Project End Date
    8/31/2024 - 3 months ago
  • Program Officer Name
    MARQUEZ, GUILLERMO
  • Budget Start Date
    9/1/2021 - 3 years ago
  • Budget End Date
    8/31/2022 - 2 years ago
  • Fiscal Year
    2021
  • Support Year
    04
  • Suffix
  • Award Notice Date
    9/1/2021 - 3 years ago

Spectro-Holographic Instrument for Dynamic Sensing of Cancer Progression

Project Summary In this application we propose to develop a native contrast optical spectroscopic sensing approach that identifies and characterizes subcellular structures and quantifies their properties when cells undergo pre- cancerous alterations, by using light scattering spectra as native optical biomarkers. Such a technique would enable simultaneous labeling of large number of subcellular and subnuclear structures without the use of stains and would be of great value for studying early cancer progression. The absence of stains also makes such methods easy to implement in time-course cancer progression studies and would be amenable for in vivo observations in humans. Although cellular alterations in organelle and nuclear structure are readily observed and studied in cancer, there are fundamental limitations in existing imaging techniques that prevent the study of very early stage pre-cancerous alterations. In contrast to dysplastic cellular alterations such as nuclear enlargement and organization, the earliest stages of carcinogenesis have much more subtle alterations that are not easily discernible with standard microscopy techniques. Perhaps the most often used imaging tool for observing cellular structure is fluorescence microscopy. It can achieve targeted contrast for specific organelles or proteins, however imaging in live cells remains limited to just a few types of fluorophores and therefore structure types. Although recently developed optogenetic methods and new live cell fluorescent probes have significantly improved the utility of fluorescence in living systems, the method is inherently limited to observing a few types of structures at relatively short time scales. An even more substantial limitation of conventional optical imaging is that it is subject to the diffraction limit and cannot discern the properties of cellular structures that are significantly smaller than a wavelength. On the other hand, electron microscopy imaging methods are destructive, involve extensive manipulations with the sample, and cannot be utilized in living systems. In order to overcome the limitations of both methods, a technique that is based on an entirely different physical principle is required. This method should ideally identify all important cellular structures in live cells, while simultaneously dynamically quantifying their properties when cells undergo pre-cancerous alterations.

IC Name
NATIONAL CANCER INSTITUTE
  • Activity
    R01
  • Administering IC
    CA
  • Application Type
    5
  • Direct Cost Amount
    1
  • Indirect Cost Amount
    0
  • Total Cost
    1
  • Sub Project Total Cost
  • ARRA Funded
    False
  • CFDA Code
    394
  • Ed Inst. Type
  • Funding ICs
    NCI:1\
  • Funding Mechanism
    Non-SBIR/STTR RPGs
  • Study Section
    ISD
  • Study Section Name
    Instrumentation and Systems Development Study Section
  • Organization Name
    BETH ISRAEL DEACONESS MEDICAL CENTER
  • Organization Department
  • Organization DUNS
    071723621
  • Organization City
    BOSTON
  • Organization State
    MA
  • Organization Country
    UNITED STATES
  • Organization Zip Code
    022155400
  • Organization District
    UNITED STATES